Ceriva

product on market Tablet or Pill Metagenics Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Ceriva
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

200 mcg
Market median: 0.15mg (41 products)
Polypeptide Complex
100 mcg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one tablet once daily with food or as directed by your healthcare practitioner.

Warnings & Precautions

Warning: Do not use if pregnant or nursing.

Caution: For adult use only. Avoid use if taking acetylcholinesterase inhibitors or cholinergic medications, or if you have a seizure disorder, cardiac arrhythmia, benign prostatic hypertrophy, asthma, chronic respiratory condition, peptic ulcer, inflammatory bowel disease, or malabsorption syndrome.

If you have suppressed immune function or are taking medication, including blood thinning medications and immunomodulators, consult your healthcare practitioner before use.

Rare but mild and temporary anxiety, mood change, sleep disturbance, dizziness, or fatigue may be experienced. Do not exceed two tablets daily. Use with caution when driving or operating machinery.

Keep out of the reach of children.

Practitioner exclusive

Contains: Milk.

Formulation Notes

Ceriva is formulated to support healthy cognition and memory by beneficially modulating the metabolism of the neurotransmitter acetylcholine and aiding neuroprotection.

This product is non-GMO and gluten-free. GF Certified Gluten-free

Cognitive & memory support

Additional Information

Storage: Keep in a cool, dry place.

GF Certified Gluten-free

Metadata

Product Details

DSLD Entry Date2022-05-19
Product TypeOther Combinations
FormTablet or Pill
DSLD ID267375
Data Updated2026-04-11
Research

Research Evidence

2
Research Sources
64
Avg Quality
2
Cochrane Review
B Huperzine A for vascular dementia.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
B Huperzine A for mild cognitive impairment.
Cochrane Review The Cochrane database of systematic reviews PubMed DOI
View all evidence for Huperzine A →
Compare

Similar Products

View all Huperzine A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.